Abstract:Background Bleomycin is a broad-spectrum glycopeptide antitumor antibiotic produced by Streptomyces verticillus . Clinically, the mixture of bleomycin A2 and bleomycin B2 is widely used in combination with other drugs for the treatment of various cancers. As a secondary metabolite, the biosynthesis of bleomycin is precisely controlled by the complex extra-/intracellular regulation mechanisms, it is imperative to investigate the global metabolic and regulatory system involved in bleomycin biosynthesis for increasing bleomycin production. Results N -acetylglucosamine (GlcNAc), the vital signaling molecule controlling the onset of development and antibiotic synthesis in Streptomyces , was found to increase the yields of bleomycins significantly in chemically defined medium. To mine the gene information relevant to GlcNAc metabolism, the DNA sequences of dasR - dasA - dasBCD - nagB and nagKA in S. verticillus were determined by chromosome walking. From the results of Real time fluorescence quantitative PCR (RT-qPCR) and electrophoretic mobility shift assays (EMSAs), the repression of the expression of nagB and nagKA by the global regulator DasR was released under induction with GlcNAc. The relief of blmT expression repression by BlmR was the main reason for increased bleomycin production. DasR, however, could not directly affect the expression of the pathway-specific repressor BlmR in the bleomycins gene cluster. With at the beginning of bleomycin synthesis, the supply of the specific precursor GDP-mannose played the key role in bleomycin production. Genetic engineering of the GDP-mannose synthesis pathway indicated that phosphomannose isomerase (ManA) and phosphomannomutase (ManB) were key enzymes for bleomycins synthesis. Here, the blmT , manA and manB co-expression strain OBlmT/ManAB was constructed. Based on GlcNAc regulation and assisted metabolic profiling analysis, the yields of bleomycin A2 and B2 were ultimately increased to 61.79 and 36.9 mg/L, respectively. Conclusions Under GlcNAc induction, the elevated production of bleomycins was mainly associated with the alleviation of the inhibition of BlmT, so blmT and specific precursor synthesis pathways were genetically engineered for bleomycins production improvement. Combination with subsequent metabolomics analysis not only effectively increased the bleomycin yield, but also extended the utilization of chitin-derived substrates in microbial-based antibiotic production.

Enhancement of Pneumocandin B0 Production in Glarea Lozoyensis by Low-Temperature Adaptive Laboratory Evolution

Novel Osmotic Stress Control Strategy for Improved Pneumocandin B0 Production in Glarea Lozoyensis Combined with a Mechanistic Analysis at the Transcriptome Level.

Metabolomics Profiling Reveals the Mechanism of Increased Pneumocandin B0 Production by Comparing Mutant and Parent Strains

Exploration of the pneumocandin biosynthetic gene cluster based on efficient CRISPR/Cas9 gene editing strategy in Glarea lozoyensis

Optimization of fermentation conditions for production of a novel antifungal metabolite by response surface methodology

Fermentation process and kinetics of novel antifungal antibiotic production

Development Of An Efficient Strategy To Improve Extracellular Polysaccharide Production Of Ganoderma Lucidum Using L-Phenylalanine As An Enhancer

Effect of fatty acids on intracellular pneumocandin B0 storage in the fermentation of Glarea lozoyensis

Effects of Cotton Seed Powder As the Seed Medium Nitrogen Source on the Morphology and Pneumocandin B0 Yield of Glarea Lozoyensis

Improvement of Cephalosporin C Production by Recombinant DNA Integration in Acremonium Chrysogenum

Fast-track adaptive laboratory evolution of Cupriavidus necator H16 with divalent metal cations

Adaptive laboratory evolution of Naematelia aurantialba under high temperature for efficient production of exopolysaccharide

Optimization of fermentation conditions for polymalic acid production by Aureobasidium pullulans BK-10

Enhancement of Bleomycin Production in Streptomyces Verticillus Through Global Metabolic Regulation of N -Acetylglucosamine and Assisted Metabolic Profiling Analysis

Enhanced amphotericin B production by genetically engineered Streptomyces nodosus

Enhanced AmB Production in Streptomyces nodosus by Fermentation Regulation and Rational Combined Feeding Strategy

GREACE-assisted adaptive laboratory evolution in endpoint fermentation broth enhances lysine production by Escherichia coli

Improving Tolerance and 1,3-Propanediol Production of Clostridium Butyricum Using Physical Mutagenesis, Adaptive Evolution and Genome Shuffling

Effect of adaptive laboratory evolution of engineered Escherichia coli in acetate on the biosynthesis of succinic acid from glucose in two-stage cultivation

Engineering Bacillus subtilis J46 for efficient utilization of galactose through adaptive laboratory evolution

Increasing the Ascomycin Yield by Relieving the Inhibition of Acetyl/Propionyl-CoA Carboxylase by the Signal Transduction Protein GlnB